US 2003/0153593 A1 · Use of CCI-779 as an antineoplastic agent

Abstract

This invention provides the use of CCI-779 in the treatment of neoplasms.

Dependent claims

A method of treating a neoplasm in a mammal in need thereof, which comprises providing to said mammal an effective amount of CCI-779.

Dependencies are inferred from the claim text.

Facts

Application

10/374,644Filed 26 Feb 2003

Priority

15 Nov 2000

Published

14 Aug 2003

Term ends

Not estimatedThe source records don’t support an estimate.

A61K 31/4745
Ortho- or peri-condensed with heterocyclic ring systems: condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
A61K 31/436
Ortho- or peri-condensed with heterocyclic ring systems: the heterocyclic ring system containing a six-membered ring having oxygen as a ring…
A61P 13/12
Drugs for disorders of the urinary system: of the kidneys
A61P 35/00
Antineoplastic agents

Family

Application60/249,077Us provisional application · filed 15 Nov 2000

Application10/010,584Continuation · filed 13 Nov 2001

Application10/374,644Continuation · filed 26 Feb 2003

US 2002/0091137 A1Published application

US 2003/0153593 A1This patent

From the US filing history. Foreign family members aren’t listed.